Chemical Compound

Senktide

CAS Registry Number 106128-89-6
Back to search Request a Quote
Senktide chemical structure
Primary Record

Senktide

In stock
1,442 g
Purity
98.2 %
CAS
106128-89-6

Compound Identifiers & Properties

CAS
106128-89-6
PubChem CID
108147
SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O
Canonical SMILES
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O)C(N)=O

Names & Synonyms

  • Senktide
  • Natalizumab
  • 106128-89-6
  • RefChem:182395
  • D05ZWG
  • Natalizumab (anti-ITGA4)
  • AC1L33FH
  • CHEMBL106124
  • Senktide trifluoroacetate salt
  • DTXSID80909926
  • HMHYXLVEFVGOPM-QKUYTOGTSA-N
  • GTPL2127
  • orb1299642
  • SCHEMBL5238634
  • H-(Suc)DF(NMeF)GLM-NH2
  • CTK8E9092
  • C40H55N7O11S
  • MFCD00076799
  • suc[Asp6,MePhe3]SP(6-11)
  • HY-P0187
  • suc[Asp6,MePhe3]SP(6-11))
  • BDBM50052524
  • CID108147
  • Succinyl-6-asp-8-Me-phe-substance P (6-11)
  • ZINC95615286
  • BAT-010203
  • CID:108147
  • CS-8091
  • Substance P (6-11), succinyl-asp(6)-Me-phe(8)-
  • Suc-[Asp6,MePhe8]substance P(6-11)
  • DA-56013
  • DA-78081
  • FS109556
  • LS-96168
  • MS-31559
  • SID:104231759
  • SUC-ASP-PHE-N-ME-PHE-GLY-LEU-MET-NH2
  • Succinyl-(Asp6,N-Me-Phe8)-Substance P (6-11)
  • J356.953E
  • RT-015687
  • B6580
  • A16945
  • G12250
  • Suc-L-Asp-Phe-N-Methyl-Phe-Gly-Leu-Met-NH2
  • 189261-10-7
  • Substance P (6-11), succinyl-aspartyl(6)-methylphenylalanine(8)-
  • [Succinyl-Asp6, NMePhe8]-Substance P (6-11)
  • [Succinyl-Asp6, NMePhe8]-Substance P (6-11),
  • C054724
  • (5S,8S,14S,17S,20S)-14,17-Dibenzyl-5-carbamoyl-20-(carboxymethyl)-8-isobutyl-15-methyl-7,10,13,16,19,22-hexaoxo-2-thia-6,9,12,15,18,21-hexaazapentacosan-25-oic acid
  • A1009254
  • Q27088780
  • (3S)-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(3-carboxypropanoylamino)-4-oxobutanoic acid
  • (3S)-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[(4-hydroxy-4-oxobutanoyl)amino]-4-oxobutanoic acid
  • 4-10-Neuromedin B (swine spinal cord), N-(3-carboxy-1-oxopropyl)-6-(N-methyl-L-phenylalanine)-7-de-L-valine-
  • L-Methioninamide, N-(3-carboxy-1-oxopropyl)-L-alpha-aspartyl-L-phenylalanyl-N-methyl-L-phenylalanylglycyl-L-leucyl-
  • N-(3-Carboxy-1-oxopropyl)-6-(N-methyl-L-phenylalanine)-7-de-L-valine-4-10-neuromedin B (swine spinal cord)
  • N-(3-Carboxy-1-oxopropyl)-L-alphaAsp-L-Phe-N-methyl-L-Phe-Gly-L-Leu-L-Met-NH2
  • N-(3-Carboxy-1-oxopropyl)-L-Asp-L-Phe-N-methyl-L-Phe-Gly-L-Leu-L-Met-NH2
  • (3S)-3-{[(1S)-1-{[(1S)-1-[({[(1S)-1-{[(1S)-1-CARBAMOYL-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}METHYL)CARBAMOYL]-2-PHENYLETHYL](METHYL)CARBAMOYL}-2-PHENYLETHYL]CARBAMOYL}-3-(3-CARBOXYPROPANAMIDO)PROPANOIC ACID
  • (3S)-4-(((2S)-1-(((2S)-1-((2-(((2S)-1-(((2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-1-oxo-3-phenylpropan-2-yl)-methylamino)-1-oxo-3-phenylpropan-2-yl)amino)-3-((4-hydroxy-4-oxobutanoyl)amino)-4-oxobutanoic acid
  • (3S)-4-[[(1S)-1-benzyl-2-[[(1S)-1-benzyl-2-[[2-[[(1S)-1-[[(1S)-1-carbamoyl-3-methylsulfanyl-propyl]carbamoyl]-3-methyl-butyl]amino]-2-oxo-ethyl]amino]-2-oxo-ethyl]-methyl-amino]-2-oxo-ethyl]amino]-3-(3-carboxypropanoylamino)-4-oxo-butanoic acid
  • (3S)-4-{[(5S,8S,14S,17S)-14-Benzyl-7,10,13-trihydroxy-5-[hydroxy(imino)methyl]-15-methyl-8-(2-methylpropyl)-16-oxo-18-phenyl-2-thia-6,9,12,15-tetraazaoctadeca-6,9,12-trien-17-yl]imino}-3-[(3-carboxy-1-hydroxypropylidene)amino]-4-hydroxybutanoic acid
  • (S)-N-((S)-1-{[(S)-1-({[(S)-1-((S)-1-Carbamoyl-3-methylsulfanyl-propylcarbamoyl)-3-methyl-butylcarbamoyl]-methyl}-carbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-2-phenyl-ethyl)-3-(3-carboxy-propionylamino)-succinamic acid
  • 4-({14-Benzyl-7,10,13-trihydroxy-5-[hydroxy(imino)methyl]-15-methyl-8-(2-methylpropyl)-16-oxo-18-phenyl-2-thia-6,9,12,15-tetraazaoctadeca-6,9,12-trien-17-yl}imino)-3-[(3-carboxy-1-hydroxypropylidene)amino]-4-hydroxybutanoic acid
  • 4-10-Neuromedin b(swine spinal cord),N-(3-carboxy-1-oxopropyl)-6-(N-methyl-L-phenylalanine)-7-de-L-valine-(9ci)